CTMX
Ticker
CytomX Therapeutics, Inc.
CTMX · Healthcare · CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to…CytomX Therapeutics, Inc. (CTMX), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 6 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Mar 17 and filed Mar 19. The most active filer was Sean A. McCarthy with 3 filings. Data as of Nov 7 2026.
Add to watchlistFilings, ttm
6
0 buys · 6 sells · 1 late
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$1.7M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Mar 17
Filed Mar 19
ADViAverage daily dollar volume
$7.6M
market data
Share price · 12M
$2.32 (-44.6%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $2.3M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
SMRecent filings
Sean A. McCarthySALE
CEO
$462K101,793 sh × $4.54
Exec Nov 6 2025
Filed Oct 16 · 7:40 PM ET † Christopher OgdenSALE Chief Financial Officer $124K
19,323 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET Marcia BelvinSALE SVP, Chief Scientific Officer $202K
31,492 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET Sean A. McCarthySALE CEO $764K
118,969 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET Yu-Waye ChuSALE Chief Medical Officer $137K
21,279 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET Sean A. McCarthySALE CEO $462K
101,793 sh × $4.54
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET Sean A. McCarthySALE CEO $149K
55,511 sh × $2.69
Exec Jun 16 2025
Filed Jun 17 2025 · 5:30 PM ET